TMEM106B-mediated SARS-CoV-2 infection allows for robust ACE2-independent infection in vitro but not in vivo
K. Yan, T. Dumenil, R. Stewart, C. R. Bishop, B. Tang, A. Suhrbier, D. J. Rawle
This study identifies TMEM106B as a key mediator of ACE2-independent SARS-CoV-2 infection in vitro but shows no in vivo neuroinvasiveness or respiratory tract replication in mice.
bioRxiv · May 8, 2024 · PreprintMicrobiology